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Abstract
Healthcare resource allocation decisions are commonly informed by com-
puter model predictions of population mean costs and health eects. It is
common to quantify the uncertainty in the prediction due to uncertain
model inputs, but methods for quantifying uncertainty due to inadequacies
in model structure are less well developed. We introduce an example of a
model that aims to predict the costs and health eects of a physical activ-
ity promoting intervention. Our goal is to develop a framework in which
we can manage our uncertainty about the costs and health eects due to
deciencies in the model structure. We describe the concept of `model dis-
crepancy': the dierence between the model evaluated at its true inputs,
and the true costs and health eects. We then propose a method for quanti-
fying discrepancy based on decomposing the cost-eectiveness model into a
series of sub-functions, and considering potential error at each sub-function.
We use a variance based sensitivity analysis to locate important sources of
discrepancy within the model in order to guide model renement. The re-
sulting improved model is judged to contain less structural error, and the
distribution on the model output better reects our true uncertainty about
the costs and eects of the intervention.
KEYWORDS: computer model, elicitation, health economics, model uncertainty,
sensitivity analysis, uncertainty analysis
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1 Introduction
Mathematical \cost-eectiveness" models are routinely used to aid healthcare re-
source allocation decisions. Such models estimate the population mean costs and
health eects of a range of decisions, and will be most helpful when their results are
unbiased and uncertainty about their estimated costs and consequences is prop-
erly specied. Two sources of uncertainty in model predictions are uncertainty
about the model input values and uncertainty about model structure.
These models are typically `law-driven' (based on our knowledge of the system)
rather than `data-driven' (tted to data), following the distinction given in Saltelli
et al. (2008). Indeed, such models are built because of a lack of data on long term
costs and health consequences. The law-driven nature of the cost-eectiveness
model has important implications for our choice of technique for managing struc-
tural uncertainty, as we discuss later.
To quantify input uncertainty, one can specify a probability distribution for the
true values of the inputs, and propagate this distribution through the model, typi-
cally using Monte Carlo sampling. In health economic modelling, this is known as
probabilistic sensitivity analysis (PSA) (Claxton et al., 2005). The danger with
reporting uncertainty based only on a PSA is that this may be interpreted as
quantifying uncertainty about the costs and health eects of the various decision
options. However, PSA only quanties uncertainty in the model output due to un-
certainty in model inputs. To properly represent uncertainty about the costs and
health eects we must also consider uncertainty in the model structure. However,
quantifying uncertainty in model structure is hard since it requires judgements
about a model's ability to faithfully represent a complex real life decision prob-
lem.
Model averaging methods can be used to assess structural uncertainty if a
complete set of plausible competing models can be built and weighted according
to some measure of model adequacy. The weighting may be based, for example,
on the posterior probability that the model is `correct', or the predictive power
of the model in a cross-validation framework. See Kadane and Lazar (2004) for a
general discussion on this topic and Jackson et al. (2009, 2010) for more focussed
discussions with respect to health economic decision model uncertainty. Model
averaging does however have limitations. If model weights are dependent on ob-
served data then we must be able to write down a likelihood function linking the
model output to the data. This will be dicult unless we have observations on
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the output of the model itself, which in the health economic context we almost
never have. If we have observations on a surrogate endpoint (say, drug ecacy at
two years in the context of wishing to predict ecacy at ten years) then we can
construct weights that relate to certain structural choices within the model, but
crucially the data will not guide our choice of the whole model structure. Hence
there may be elements within each model that lead to dierent predictions of the
output, but are untested in the model averaging framework.
The problem of model structure uncertainty has also been addressed in the
computer models literature, but from a dierent perspective. Rather than focusing
on generating weights for models within some set, methods are directed towards
making inferences about model \discrepancy": the dierence between the model
run at its `best' or `true' input, and the true value of the output quantity (Kennedy
and O'Hagan, 2001). Given a model, written as a function f , with (uncertain)
inputs X, the key expression is equation (1), which links the model output Y =
f(X) to the true, but unknown value of the target quantity we wish to predict,
Z:
Z = f(X) + z; (1)
The discrepancy term, z, quanties the structural error : the dierence between
the output of the model evaluated at its true inputs and the true target quantity.
We are explicitly recognising in equation (1) that our model may be decient,
but note that when we speak about model deciency we are not concerned with
mistakes, `slips', `lapses' or other errors of implementation (for a discussion on this
topic see Chilcott et al., 2010b). Rather, we are concerned with deciencies arising
as a result of the gap between our model of reality, and reality itself. Obtaining a
joint distribution that reects our beliefs about inputs and discrepancies, p(X; z),
allows us then to fully quantify our uncertainty in the target quantity due to
both uncertain inputs and uncertain structure. This approach has the important
advantage that only a single model need be built, though methods for making
inferences about discrepancy in the context of multiple models have also been
explored (Goldstein and Rougier, 2009).
In our paper we explore the feasibility of the discrepancy method in assessing
structural uncertainty in a cost eectiveness model for a physical activity pro-
moting intervention. In section 2 we describe our `base case' model and report
results without any assessment of structural uncertainty. In section 3 we describe
our proposed method for quantifying the model discrepancy z. We describe the
application of the method to our model in section 4 and present results in section
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5. We discuss implications and potential further developments in the nal section.
2 Case study: a physical activity intervention
cost eectiveness model
We based our case study on a cost-eectiveness model that was developed to
support the National Institute for Health and Clinical Excellence (NICE) physical
activity guidance (NICE, 2006). NICE is the organisation in the UK that makes
recommendations to the National Health Service and other care providers on the
clinical and cost eectiveness of interventions for promoting health and treating
disease. The majority of NICE's recommendations and guidance products are
informed by mathematical model predictions.
Our simplied version of the NICE model aims to predict the incremental net
benet of two competing decision options: exercise on prescription (e.g. from
a general medical practitioner) to promote physical activity (the `intervention'),
and a `do nothing' scenario (`no intervention'). Incremental net benet, measured
in monetary units, is dened as
Z = (E2   E1)  (C2   C1) = E  C; (2)
where Ed and Cd are respectively the population mean health eects and costs
associated with decisions d = 1; 2, and  is the value in monetary units that the
decision maker places on one unit of health eect. We assume that the intervention
impacts on health by reducing the risks of three diseases: coronary heart disease
(CHD), stroke and diabetes. The health eects included in the model are those
that relate to these three diseases, and we count costs that accrue as a result of
the treatment of the three diseases, as well as those that relate to the intervention
itself.
2.1 Description of `base case' model - no assessment of
structural uncertainty
Our model is a simple static cohort model which can be viewed as a decision tree
(gure 1). The left-most node represents the two decision options, d = 1, no
intervention, and d = 2, the exercise prescription intervention. The rst chance
node represents the probability of new exercise under each decision option, with
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Figure 1: The model expressed as a decision tree
the second node representing the probability of maintenance of exercise conditional
on new exercise. The third node represents the probability of eight mutually
exclusive health states conditional on each of the three outcomes from the rst
two nodes: exercise that is maintained, exercise that is not maintained, and no
exercise (sedentary lifestyle).
The structure of the model represents our beliefs about the causal links be-
tween the intervention and exercise, and exercise and health outcomes. There are
no data available that relate to the model outputs; we have not observed costs
and health outcomes for control and treatment groups on the exercise interven-
tion. However, separate data sources are available regarding the eectiveness of
the intervention in promoting exercise, and the risks of the various disease out-
comes for active versus sedentary patients, and the availability of such data has
guided the choice of model structure.
In our model each comorbid health state (e.g. the state of CHD and stroke)
is treated as having a single onset point in time. Individuals do not progress, say,
from the disease free state, to CHD and then to CHD plus stroke as they might
do in reality. This is clearly unrealistic and is a consequence of the choice to use a
very simple decision tree structure. Modelling sequential events is possible using a
decision tree structure, but the number of terminal tree branches quickly becomes
very large in all but the simplest of problems (Sonnenberg and Beck, 1993). A
Markov or discrete event model structure would be more suited to addressing our
decision problem (see Karnon (2003) for a comparison of these methods), but
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we have chosen to retain the important features of the structure of the model
published by NICE, upon which our case study is based (NICE, 2006).
We denote the set of eight health states, disease free, CHD alone, stroke alone,
diabetes alone, CHD and stroke, CHD and diabetes, stroke and diabetes, CHD and
stroke and diabetes as H = fhj; j = 1; : : : ; 8g, where j indexes the set in the order
given above. Each of the eight health states hj 2 H, under each decision option d,
has a cost cdj (measured in $), a health eect (measured in Quality Adjusted Life
Years) qdj, and a probability of occurrence pdj (as approximated by the relative
frequency with which this health state occurs within a large cohort). Total costs
and total health eects for decision d are obtained by summing over health states,
i.e. Cd =
P8
j=1 cdjpdj and Qd =
P8
j=1 qdjpdj. Given these, the model predicted
incremental net benet, Y is
Y = (Q2  Q1)  (C2   C1) = Q C: (3)
The costs cdj, health eects qdj, and health state probabilities pdj are not
themselves input parameters in the model, but instead are functions of input
parameters. There are 24 uncertain and three xed input parameters that relate
to the costs, quality of life and epidemiology of CHD, stroke and diabetes, and the
eectiveness of the intervention in increasing physical activity. These inputs are
denotedX = X1; : : : ; X27, and uncertainty is represented via the joint distribution
p(X). The input quantities and their distributions are described in tables 2 and
3 in appendix A.
Finally, we denote the deterministic function that links the model inputs to
the model output as f , i.e. Y = f(X), and call this the base case model.
2.2 Base case model results
The model function (which we describe in detail in section 4) was implemented in
R (R Development Core Team, 2010). We sampled the input space and ran the
model 100,000 times. The mean of the model output, Y , at =$20,000/QALY
was $247 and the 95% credible interval was (-$315, $1002). The probability that
the intervention is cost-eective, P (INB > 0), at  =$20,000 was 0.77. Results
for the base case model are shown graphically in gure 2 (note that gure 2 also
includes the results for the `with discrepancy' and `after remodelling' analyses that
are reported in section 5.1).
Figure 2a shows the cost-eectiveness plane (with 100 Monte Carlo samples).
The sloped line shows the willingness to pay threshold of $20,000 per QALY. To
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aid clarity gure 2b is a contour plot representation of the cost eectiveness plane,
showing the 95th percentile of an empirical kernal density estimate of the joint dis-
tribution of costs and eects. Figure 2c shows the cost-eectiveness acceptability
curve (i.e. a plot of P (INB > 0) against ) for values of  from $0/QALY to
$40,000/QALY. Finally, gure 2d shows the kernel density estimate for Y , the
base case model estimate of the incremental net benet at  =$20,000.
A mean incremental net benet of $247 at =$20,000/QALY implies that, on
average, the intervention will accrue costs and health eects that have a positive
net value of $247 per person treated. The probabilistic sensitivity analysis implies
that, at =$20,000/QALY, a choice to recommend the intervention would have
a probability of 0.77 of being better than the choice not to recommend.
3 Managing uncertainty due to structure: a dis-
crepancy approach
For the decision maker to base their decision on the model output, the model must
have credibility. The model must be judged good enough to support the decision
being made. The primary goal of our analysis is therefore to provide a means
for quantifying judgements about structural error and specically to determine
the relative importance of structural compared to input uncertainty in addressing
the decision problem. If uncertainty about structural error is large then we may
wish to review the model structure. Conversely, if we can demonstrate that the
uncertainty about structural error is small in comparison to that due to input
uncertainty, then we have a stronger claim to have built a credible model.
In building the base case model we made a series of assumptions, for example
we assumed that occurrences of CHD, stroke and diabetes are independent at the
level of the individual and therefore that disease risks act multiplicatively. Such
assumptions drive the structural choices that we make when formulating a model,
and incorrect assumptions will lead to structural error. We must therefore focus
our attention on the assumptions within a model if we are to assess its adequacy
and properly quantify our uncertainty about the target quantity.
In the model averaging framework new models would be built to incorporate
the set of alternative assumptions believed plausible (with new models possibly
being just minor variants of the existing model). The models would then be
weighted according to some measure of adequacy in relation to data, D. Given
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Figure 2: Model output shown as (a) cost-eectiveness plane (b) cost-eectiveness
plane contour plot (c) cost-eectiveness acceptability curve (d) incremental net
benet empirical density. Results are shown for the base case model (section 2.2),
`with discrepancy' analysis (section 5.1) and `after remodelling' analysis (section
5.6).
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a set of models fMi; i 2 Ig and adequacy measure !(), the distribution of the
target incremental net benet is given by
p(ZjD) =
X
i2I
p(ZjMi; D)!(MijD): (4)
If we believe that one of the models in our set is true (i.e. that fMi; i 2 Ig is \M-
closed" in the terminology of Bernardo and Smith, 1994), and can specify prior
model probabilities p(Mi), then the models can be weighted by their posterior
probabilities given the data,
p(MijD) = p(DjMi)p(Mi)P
i2I p(DjMi)p(Mi)
; (5)
For the M-closed case this is a consistent estimation procedure, in the sense that
as more data are collected the posterior probability of the true model will converge
to 1. However, if we believe that none of the models is correct (i.e. we have an
\M-open" set) then this approach is no longer consistent. In the M-open case
Jackson et al. (2010) propose instead that weights are based on the predictive
probability of Mi given a replicate data set.
A more fundamental problem in the context of health economic decision mod-
elling is the usual absence of data against which to measure the adequacy of the
model in its entirety. We do not measure overall costs and health eects over
extended time periods under competing decision options. In the absence of ob-
servations on the model output Z, weights could be based on the judgement of
the modeller and/or decision maker, though making probability statements about
models, which are by denition abstract non-observables is likely to be very di-
cult.
We therefore propose a dierent approach based on specifying a distribution
for the model discrepancy, z, as dened in equation (1). In contrast to the model
averaging approach we do not attempt to make assessments about the adequacy
of the model structure in relation to alternative structures; we instead assess how
large an error might be due to the structure of the model at hand.
3.1 Discrepancy between model output and reality
In many applications in the physical sciences the target quantity predicted by a
model can be partitioned asZ = fZo;Zug, where there are (noisy) observationsw
on Zo, but no observations of Zu. For example, we may have historic observations
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on the output variable, and wish to predict future observations (forecasting),
or we may have observations at a set of points in space and wish to predict
values at locations in between (interpolation). Kennedy and O'Hagan (2001)
propose a method for fully accounting for the uncertainty in Z, given w, via
the model discrepancy within a Bayesian framework. However, in the context of
health economics, we do not measure the costs and health consequences of sets
of competing decisions, making this data driven method impossible. Specifying
p(z) directly therefore requires some form of elicitation of beliefs. See Garthwaite
et al. (2005) and O'Hagan et al. (2006) for a discussion of methods.
Making meaningful judgements about the model discrepancy will be dicult,
though it should always be possible to make a crude evaluation of a plausible
range of orders of magnitude of z, for example by asking questions like `could
the true incremental net benet of decision 1 over decision 2 be a billion pounds
greater than that predicted by the model, or a million pounds greater, or only a
hundred pounds greater?' However, it may be easier to make judgements about z
indirectly. If we consider f in more detail we may be able to determine where in
the model structural errors are likely to be located, and what their consequences
might be. We therefore propose making judgements about discrepancy at the
sub-function level.
3.2 Discrepancy at the `sub-function' level
Any model f , except the most trivial, can be decomposed into a series of sub-
functions that link the model inputs to the model output. So for example, a
decomposition of the hypothetical model
Y = f(X1; : : : ; X7) =
(
(X1X2 +X3X4)

1
1 +X5
 X6)
 X7; (6)
might be in terms of sub-functions f1, f2 and f3, with Y1 = f1(X1; : : : ; X4) =
X1X2+X3X4, Y2 = f2(X5; X6) =

1
1+X5
 X6
and Y = f3(Y1; Y2; X7) = Y1Y2 X7.
The sub-functions f1, f2 and f3 could be decomposed into further sub-functions,
and so on. The inputs to each sub-function may contain both elements of the
original input vector X = (X1; : : : ; X7) and outputs from other sub-functions in
the decomposition. We call the output of each sub-function (unless it is the nal
model output, Y ) an intermediate parameter.
For each sub-function, we ask the question `would this sub-function, if evalu-
ated at the true values of its inputs, result in the true value of the sub-function
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output?' If not then we recognise potential structural error and introduce an un-
certain discrepancy term, i, either on the additive scale, i.e. Yi = fi() + i, or
multiplicative scale, i.e. log(Yi) = logffi()g + log(i). The idea is that, because
each sub-function represents a much simpler process than the full model f , making
judgements about discrepancy in fi will be easier than making judgements about
discrepancy in f .
Repeating the process for all sub-functions in the model will leave us with a
series of n discrepancy terms, which we denote  = (1; : : : ; n). Note that for
some sub-functions we will judge there is no structural error, usually when an
intermediate parameter is by denition equal to the sub-function that generates
it.
There will not usually be a unique decomposition of the model f into a series
of sub-functions that links the model inputs X to the model output Y . However,
some decompositions will be more useful than others for assessing discrepancy.
Following the advice that it is preferable to elicit beliefs about observable quanti-
ties (O'Hagan et al., 2006), we search for decompositions where both inputs and
outputs of the sub-functions are observable.
Once we have introduced discrepancy terms at the locations within the model
where we judge there is potential structural error, we must make judgements about
the discrepancies via the specication of the joint probability distribution p(X; ).
We assume in our case study that discrepancies are independent of inputs, such
that we can factorise the joint density p(X; )=p(X)p(). This independence
assumption does not need to hold for the discrepancy method to be valid, but
specication of p() independent of p(X) will clearly be easier than specifying
p(X; ).
We next consider the mean and variance for each discrepancy term i; i =
1; : : : ; n. We make judgements about the sizes of the discrepancies relative to the
mean values of the corresponding intermediate parameters, and set variances such
that
p
var(i) = vijE(Yi)j, with vi chosen to reect our judgements. Determining
plausible values for vi may not be a trivial task, a point to which we return in the
discussion. We treat each i as independent of all other uncertain quantities, unless
there are constraints that prevent this (a constraint would arise, for example, in
relation to a set of population proportion parameters that must sum to one) or
unless there are good reasons to assume strong correlation between terms. Finally
we select appropriate distributions with the specied means and variances.
Propagating the uncertainty we have specied for  through the model, along
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with the uncertainty in the inputs, X, allows us to check that the uncertainty in
Z that our specication of p() implies is plausible. If this is not the case then
we must rethink our choice of distributions for the components of , most easily
through altering our choices for vi.
The sub-function discrepancy approach has two important consequences. Firstly,
if we can adequately make judgements about all the discrepancy terms in the
model (there may be many) then we will derive p(z) and hence be able to make
statements about our uncertainty about the incremental net benet that incorpo-
rates beliefs about both inputs and structure. Perhaps more usefully though, we
can use sensitivity analysis techniques to investigate the relative importance of the
dierent structural errors, allowing us improve the parts of the model where this
is most needed. If, after repeating the sensitivity analysis in our improved model,
we nd that discrepancies now have a lesser impact on the output uncertainty,
then we have in an important sense built a more robust model structure.
4 Applying the sub-function discrepancy method
to our physical activity model
We return to our base case physical activity model, and beginning at the net
benet equation (3), work `backwards' through the model, assessing potential
structural error at each sub-function.
4.1 Assessment of sub-function generating the output pa-
rameter Y
The model output, Y predicts the incremental net benet, as dened in equation
(3). Evaluation of equation (3) at the true values of Q and C would, by
denition, result in the true value of the incremental net benet, Z, so there is no
structural error at this point in the model, and therefore no discrepancy term.
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4.2 Assessment of sub-function generating the intermedi-
ate parameter Q
The incremental health eect of the intervention over the non-intervention, Q
is
Q =
8X
j=1
p2jq2j  
8X
j=1
p1jq1j; (7)
where pdj and qdj are the probabilities and discounted health eects in QALYs
respectively for health state hj under decision d. Future health eects (and future
costs) are discounted to reect time preference whereby higher value is placed
on benets that occur in the near future than on those occurring in the distant
future. See Krahn and Gafni (1993) for a discussion of the role of discounting in
health economic evaluation.
Health eects for each state are assumed to be equal regardless of the decision,
i.e. that q1j = q2j = qj, and therefore that
Q =
8X
j=1
(p2j   p1j)qj =
8X
j=1
(p2j   p1j)(qj   q1) =
8X
j=1
(p2j   p1j)q(dec)j ; (8)
where the nal term is a re-expression in terms of the decremental health eect,
q
(dec)
j relative to the disease free state j = 1.
We ask the question, `given the true values of pdj and qj, does (8) result in
the true value of Q?' Because we imagine that the intervention could have an
impact on a number of diseases other than CHD, stroke and diabetes we recognise
potential structural error and introduce an uncertain additive discrepancy term,
Q into (8), which becomes
Q =
8X
j=1
(p2j   p1j)q(dec)j + Q: (9)
Since exercise can result in poor health outcomes as well as good outcomes,
for example through musculo-skeletal injuries or accidents, we specify a mean of
zero for Q. We could assume a non-zero mean for Q if we felt that increased
exercise was likely to be on balance benecial. This will have the eect of shifting
the mean of the model output unless the sub-function related to the discrepancy
is entirely unimportant. Introducing discrepancy terms that have non-zero mean
may well be reasonable, but by doing so we are eectively making a judgement
that the base case model is `wrong'.
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We judge that Q is unlikely to be more than 10% of Q, and we represent
our beliefs about Q using a normal distribution with a standard deviation equal
to 5% of the mean of Q, i.e. Q  N[0; f0:05 E(Q)g2].
4.3 Assessment of sub-function generating the intermedi-
ate parameter C
The incremental cost of the intervention over the non-intervention, C is
C =
8X
j=1
p2jc2j  
8X
j=1
p1jc1j; (10)
where pdj and cdj are the probabilities and discounted costs respectively that are
associated with health state hj under decision d.
Costs, not including the cost of the intervention itself c0, are assumed to be
equal across decision arms, i.e. that c2j = c1j + c0, and therefore that
C =
8X
j=1
p2j(c1j + c0) 
8X
j=1
p1jc1j = c0 +
8X
j=1
(p2j   p1j)c1j; (11)
where c0 is a model input.
As above, there may be costs that relate to diseases other than CHD, stroke
and diabetes that are not included in C and we therefore introduce an additive
discrepancy term, C , and specify that C  N[0; f0:05 E(C)g2].
4.4 Assessment of sub-function generating the intermedi-
ate parameters c1j
The intermediate parameters c1j represent the discounted cost associated with
the eight health states. In the base case model the costs for the eight states are
derived from the costs associated with the three individual diseases, with costs for
comorbid states assumed to be the sum of the costs for the constituent diseases,
so for example
c1;8 = cchd + cstr + cdm: (12)
Costs may not be additive in this way, so we introduce additive discrepancy terms,
cj , for the intermediate parameters that relate to the comorbid states, c1j j =
5; : : : ; 8.
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We judge that comorbid state costs could be higher or lower than the sum of the
constituent costs, so we assumed a mean of zero for each discrepancy term, cj ; j =
5; : : : ; 8. We represent beliefs about cj via cj  N[0; f0:05  E(cj)g2]; j =
5; : : : ; 8.
4.5 Assessment of sub-function generating the intermedi-
ate parameters cchd, cstr and cdm
The discounted costs for CHD, stroke and diabetes are
ck = c

k  k; (13)
where k indexes the set fCHD; stroke; diabetesg. Costs (other than the cost of the
intervention) are assumed to occur at some time in the future, and are discounted
at 3.5% per year. The parameters ck represent undiscounted costs, and k, are
the discounting factors for the length of time between the intervention and the
occurrence of the relevant health outcomes.
Given true values for ck and k equation (13) will result in a true value for ck,
and there is no structural error at this point.
4.6 Assessment of sub-function generating the intermedi-
ate parameters cchd, c

str and c

dm
The undiscounted mean per-person lifetime costs for CHD, stroke and diabetes
are
ck =
tk
nk

age
(dth)
k   age(onst)k

; (14)
where k indexes the set fCHD; stroke; diabetesg, and where tk are total annual
NHS costs for disease k, and where nk are UK prevalent cases of disease k for the
same year. The parameters tk; nk; age
(dth)
k and age
(onst) are model inputs.
Mean per person undiscounted costs are calculated as the mean per person
annual NHS cost multiplied by the mean length of time in the disease state. If
the per person per year cost of disease is dependent on the length of time the
individual spends in the disease state (e.g. if costs are greater near to the end of
life), then cchd, c

str and c

dm as calculated will not equal the mean per person per
year costs. To properly calculate the mean we need to know the joint distribution
of the costs and length of time in the disease state. To account for the dierence
we introduce discrepancy terms ck .
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We judge that disease costs could in reality be higher or lower than the mod-
elled costs as a result of the structural error, so we assume a mean of zero for
each discrepancy term, ck . We represent beliefs about ck via ck  N[0; f0:05
E(ck)g2].
4.7 Assessment of sub-function generating the intermedi-
ate parameters chd, str and dm
The discounting factors for CHD, stroke and diabetes are
k =

1
1 + 
lk
; (15)
where lk is the mean length of life remaining at the time of intervention for disease
k 2 fCHD; stroke; diabetesg, and  is the per-year discount rate for both costs
and health eects. The mean length of life remaining, lk, is given by
lk =
1
2

age
(onst)
k + age
(dth)
k

  age(int); (16)
where age
(onst)
k is the mean age of onset of disease k, age
(dth)
k is the mean age of
death from disease k and age(int) is the mean age of the cohort at the time of the
intervention. The parameters ; age
(dth)
k ; age
(onst) and age(int) are model inputs.
In the base case model we assume that the costs of each disease will be realised
at a time midway between the average age of disease onset, and the average age
of death from that disease. This is not necessarily true and we introduce additive
discrepancy terms k .
Discount factors must lie in (0; 1], and so discrepancies must lie in ( k; 1 k].
To satisfy this constraint we assume that k+ k follows a beta distribution. We
have no reason to believe that the true values of the discount rates will be higher
or lower than the modelled values, so we assume that k has mean zero for all k.
As above, we assume that the standard deviation is 5% of the mean value of the
intermediate parameter, i.e. that
p
var(k) = 0:05E(k).
See Appendix C for details of the calculation of Dirichlet distribution hyperpa-
rameters that satisfy these requirements. The more general Dirichlet distribution
specication of uncertainty is required for other discrepancy terms in the model,
so for brevity we treat k+ k and 1  (k+ k) as `sum-to-one' parameters and
the beta distribution as a special case of the Dirichlet distribution.
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4.8 Assessment of sub-function generating the intermedi-
ate parameters q
(dec)
j
The intermediate parameters q
(dec)
j represent the discounted decremental health
eects (in QALYs) associated with the eight health states. In the base case model
these terms are derived from the discounted decremental health eects associated
with the three individual diseases, with decremental eects for comorbid states
assumed to be the sum of the decremental eects for the constituent diseases.
This means that, for example
q
(dec)
8 = q
(dec)
chd + q
(dec)
str + q
(dec)
dm ; (17)
where the parameters q
(dec)
chd , q
(dec)
str and q
(dec)
dm are model inputs. Decremental health
eects may not be additive in this way, so we introduce discrepancy terms qj for
the comorbid health states j = 5; : : : ; 8.
We judge that comorbid state decremental health eects could be higher or
lower than the sum of the constituent terms, so assume a mean of zero for each
discrepancy term, qj ; j = 5; : : : ; 8. We represent beliefs about qj via qj 
N[0; f0:05 E(qj)g2]; j = 5; : : : ; 8.
4.9 Assessment of sub-function generating the intermedi-
ate parameters pdj
The proportions of the population who are expected to experience each disease
state j = 1; : : : ; 8 under decision options d = 1; 2 are
pdj = p
(ex)
d p
(mnt)
d r
(ex)
j + p
(ex)
d

1  p(mnt)d

r
(sed)
j +

1  p(ex)d

r
(sed)
j ; (18)
where r
(ex)
j and r
(sed)
j are the risks of disease state j in those who exercise and
in those who are sedentary, respectively. The probability of new exercise under
decision option d is p
(ex)
d , and the probability of maintenance of exercise is p
(mnt)
d .
The parameters p
(ex)
d and p
(mnt)
d are model inputs.
Parameters dening health state probabilities lie in [0; 1], and must sum to
one over j, so discrepancies must lie in [ pdj; 1  pdj], and must sum to zero over
j. To satisfy this constraint we assume a Dirichlet distribution for pdj + pdj .
We have no reason to believe that the true values of the health state prob-
abilities would be higher or lower than the modelled values, so we assume that
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E(pdj) = 0; 8d; j. We assume that the standard deviation was 5% of the mean
value of the intermediate parameter, i.e.
1
8
8X
j=1
q
var(pdj)
E(pdj)
= 0:05: (19)
See Appendix C for details of the calculation of the Dirichlet hyperparameters
that satisfy these requirements.
4.10 Assessment of sub-function generating the interme-
diate parameters r
(ex)
j and r
(sed)
j
The parameters r
(ex)
j and r
(sed)
j represent the risks of health state j in a population
that exercises and in a sedentary population, respectively. In the base case model
we assume that occurrences of CHD, stroke and diabetes are independent, and
therefore that the r
(ex)
chd ; r
(ex)
str and r
(ex)
dm act multiplicatively to generate the r
(ex)
j
(and similarly multiplicatively in the sedentary population). So for example,
r
(ex)
1 = (1  r(ex)chd )(1  r(ex)str )(1  r(ex)dm ): (20)
We assume that occurrences of CHD, stroke and diabetes are independent,
which may not be true, so we introduce additive discrepancy terms 
r
(sed)
j
and 
r
(ex)
j
.
Following the same argument as that in 4.9 we assume a Dirichlet distributions
for r
(ex)
j + r(ex)j
and for r
(sed)
j + r(sed)j
. We have no reason to believe that the true
values of the disease risks would be higher or lower than the modelled values,
so we assume that E(
r
(ex)
j
) = E(
r
(sed)
j
) = 0; 8j. We assume that the standard
deviations were 5% of the mean values of the intermediate parameters, i.e.
1
8
8X
j=1
r
var


r
(ex)
j

E

r
(ex)
j
 = 1
8
8X
j=1
r
var


r
(sed)
j

E

r
(sed)
j
 = 0:05: (21)
4.11 Assessment of sub-function generating the interme-
diate parameters r
(ex)
k
The parameters r
(ex)
k where k indexes the set fCHD; stroke; diabetesg represent
the risks of CHD, stroke and diabetes in those who exercise. They are calculated
by multiplying baseline risk by the relative risk of disease given exercise, i.e.
r
(ex)
k = r
(sed)
k RRk; (22)
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where r
(sed)
k and RRk are model inputs.
Given true values for r
(sed)
k and RRk, sub-function (22) will result in the true
value of r
(ex)
k by denition of a relative risk, so there is no structural error at this
point.
5 Results of discrepancy analysis
A total of 48 discrepancy terms were introduced into the model. The addition of
the discrepancy terms `corrects' any structural error, and allows us now to write
Z = f (X; ); (23)
where f  takes the same functional form as f , but with the inclusion of the
discrepancy terms as described in section 4.
5.1 Model output after inclusion of discrepancy terms
We sampled the input and discrepancy distributions and ran the model f  100,000
times. This resulted in a predicted mean incremental net benet of $247, which is
equal to the that predicted by the base case model. The 95% credible interval was
-$886 to $1444, which is wider than that of the base case model, reecting the
recognition of our additional uncertainty about the true incremental net benet
due to possible model structural error.
Returning to gure 2, we note the larger cloud of points on the cost-eectiveness
plane (gures 2a and 2b), reecting the additional uncertainty. The additional
uncertainty has reduced the probability that the intervention is cost-eective,
P (INB > 0), at  =$20,000 to 0.66 (closer to the value of 0.5 that represents com-
plete uncertainty), and attened the cost eectiveness acceptability curve towards
the horizontal line at P (INB > 0) = 0:5 (gure 2c). The additional uncertainty
is also reected in the wider empirical distribution in gure 2d.
5.2 Determining important structural errors via variance
based sensitivity analysis
Following our analysis of structural error we may then wish to make improvements
to the model. It is unlikely that all the sub-model discrepancy terms are equally
`important', by which we mean that some terms may be located in parts of the
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model in which structural errors contribute very little to uncertainty about Z, the
incremental net benet. If we can identify the most important discrepancy terms,
we can consider reducing structural errors through better modelling, perhaps by
relaxing certain assumptions, or by including features that were omitted initially.
Similarly, identifying unimportant discrepancy terms will tell us where it is not
worth improving the model.
Note that any re-modelling following a sensitivity analysis may not reduce
uncertainty about Z, for example if the improved model structure introduces
new, uncertain parameters. In this situation we are eectively `transferring' our
uncertainty from structure to inputs. This may be helpful simply because input
uncertainty is generally easier to manage, but in any case we believe that a formal
consideration of the balance between uncertainty due to model structure and
uncertainty due to model inputs is desirable.
We can identify a set of important discrepancy terms using standard sensitivity
analysis techniques. A considerable number of methods exist (Saltelli et al., 2008),
but for our purposes we have chosen to use a variance based sensitivity analysis
approach. In this approach the measure of importance for each discrepancy term,
i i = 1; : : : ; n, is dened as its `main eect index',
varifE(Zji)g
var(Z)
: (24)
Given the identity var(Z) = varifE(Zji)g+Eifvar(Zji)g the main eect index
gives the expected reduction in the variance of Z obtained by learning the value
of i.
The main eect index for uncorrelated discrepancy terms is straightforward to
calculate using Monte Carlo methods. In this case E(Zji) can be approximated
by
E(Zji)  1
S
SX
s=1
f (xs;  i;s; i); (25)
where f(xs;  i;s); s = 1; : : : ; Sg is a (large) sample from the distribution p(X;  i).
However, if i is correlated with other discrepancy terms or inputs, then
this method would require us to draw samples from the conditional distribution
p(X;  iji). Such conditional distributions may not be known, so we propose an
alternative approximation method. See appendix B.
Following a variance based sensitivity analysis of the discrepancy terms in our
model, eight of the terms appeared to be important, having main eects > 5%.
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The pattern of importance suggests that re-expressing the sub-functions for the
parameters pdj is key to reducing structural error (table 1).
Table 1: Main eect indexes for discrepancy terms (> 5% in bold)
Discrepancy Main eect Discrepancy Main eect Discrepancy Main eect

r
(ex)
1
0.002 p1;1 0.266 cchd 0.002

r
(ex)
2
0.002 p1;2 0.128 cstr 0.002

r
(ex)
3
0.003 p1;3 0.076 cdm 0.001

r
(ex)
4
0.002 p1;4 0.002 dchd 0.002

r
(ex)
5
0.003 p1;5 0.054 dstr 0.002

r
(ex)
6
0.002 p1;6 0.025 ddm 0.002

r
(ex)
7
0.003 p1;7 0.014 q5 0.002

r
(ex)
8
0.004 p1;8 0.010 q6 0.002

r
(sed)
1
0.002 p2;1 0.257 q7 0.002

r
(sed)
2
0.002 p2;2 0.124 q8 0.002

r
(sed)
3
0.002 p2;3 0.076 c5 0.002

r
(sed)
4
0.002 p2;4 0.002 c6 0.002

r
(sed)
5
0.002 p2;5 0.049 c7 0.002

r
(sed)
6
0.002 p2;6 0.025 c8 0.002

r
(sed)
7
0.002 p2;7 0.013 q 0.003

r
(sed)
8
0.002 p2;8 0.008 c 0.001
5.3 The relative importance of parameter to structural
error uncertainty
We may also wish to understand the relative importance of the contributions of
uncertainty about structural error and uncertainty about input parameters to the
overall uncertainty in Z. We can measure this using the structural parameter
uncertainty ratio, which we dene as
varfEX(Zj)g
varXfE(ZjX)g : (26)
This is straightforward to calculate if  is independent ofX since EX(Zj = 0) =
EXff (X; )j = 0g = EXff(X; 0)g and E(ZjX = x) = Eff (X; )jX =
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xg = Eff(x; )g. If  and X are not independent calculating the conditional
expectations is more dicult, though methods are available (Oakley and O'Hagan,
2004).
The structural parameter uncertainty ratio in our model is 2.0 indicating that,
given our specication of discrepancy, learning the discrepancy terms would result
in double the expected reduction in the variance of the output compared with
the expected reduction in variance on learning the true values of all the input
parameters.
5.4 Analysis of robustness to dierent choices of vi
In our case study we set vi (the ratio of the discrepancy standard deviation to
the mean of the corresponding intermediate parameter) to 5% equally for all dis-
crepancy terms, judging this to be an appropriate reection of the likely range
of structural error. The resulting additional uncertainty in the model output was
plausible, and the variance based sensitivity analysis implied that there was impor-
tant structural error in the sub-model that generates the health state probability
parameters, pdj (section 4.9).
In order to test the robustness of our conclusion to minor variations in the
specication of the discrepancies we altered values for vi over a plausible range. We
grouped the discrepancy terms into four sets: terms relating to cost parameters,
terms relating to health eect parameters, terms relating to population proportion
parameters, and terms relating to the discount factors. Within each set the values
for vi were either doubled, halved or maintained at 5%. Given three levels for vi
and four sets of discrepancy terms there are 34 = 81 combinations of choices for
vi including our original specication of vi = 5% for all i.
In all 81 cases a very similar pattern of main eect indexes to that reported
in table 1 was observed, with the pdj terms dominating, indicating robustness to
choices of vi over the range 2.5% to 10%.
5.5 Remodelling the sub-functions where there is impor-
tant structural error
Variance based sensitivity analysis has identied pdj to be important discrepancy
terms, indicating that we have important structural error in the sub-model that
generates the health state probability parameters, pdj.
Strong, Oakley, Chilcott Health Economic Structural Uncertainty 24
In the base case model the proportion of people who begin and then maintain
exercise is assumed constant over time. If we believe that there will be a decline
in the proportion of people who exercise over time then we could re-structure the
model sub-function to reect this. We could, for example, assume an exponential
decline, whereby the proportion exercising at each year in the future is equal
to the proportion exercising in the previous year multiplied by some (uncertain)
constant. If the risk of each disease state j decreased (increased for the well state)
linearly from r
(sed)
j to r
(ex)
j with increasing time spent exercising (with a threshold
achieved after, say, four years exercise), then we could write
pdj =

1  p(ex)d

r
(sed)
j + p
(ex)
d (1 md) r(sed)j
+ p
(ex)
d
 
md  m2d
1
4
r
(ex)
j +
3
4
r
(sed)
j

+ p
(ex)
d
 
m2d  m3d
1
2
r
(ex)
j +
1
2
r
(sed)
j

+ p
(ex)
d
 
m3d  m4d
3
4
r
(ex)
j +
1
4
r
(sed)
j

+ p
(ex)
d m
4
dr
(ex)
j ; (27)
where md is the proportion of the population who exercised in year t who continue
to exercise in year t+ 1, under decision d.
To complete the new model specication we need to specify distributions for
m1 and m2. We assume that m1 and m2 are jointly normally distributed with
means of 0.5, variances of 0.01 and a correlation of 0.9.
5.6 Results following sub-function remodelling
The mean net benet following remodelling was $71 (-$273 to $572), with the
probability that the intervention is cost-eective, P (INB > 0), at  =$20,000
equal to 0.59. Returning again to gure 2 we see that there is now a smaller cloud
a points on the cost-eectiveness plane, and that these are shifted towards the left
and the line of no eect (at Q = 0). The cost-eectiveness acceptability curve
(gure 2c) suggests that following remodelling we predict that the intervention
has a lower probability of being cost-eective than predicted by the base case
model at all values of . The leftwards shift of the incremental net benet density
towards zero supports this (gure 2d).
By re-structuring the important sub-function in the model to better incor-
porate our beliefs about real-world processes, we nd that the incremental net
benet distribution is shifted downwards. This is due to our judgement that a
proportion of those who begin new exercise will cease exercising, and that instead
of this drop being a single step change, the fall will be exponential over time.
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This results in a lower proportion of maintained exercise in both the intervention
and non-intervention groups, and a lower absolute reduction in disease risk and
smaller incremental benet.
6 Discussion
We have presented a discrepancy modelling approach that allows us to quantify
our judgements about how close model predictions will be to reality. We incorpo-
rate our beliefs about structural error through the addition of discrepancy terms
at the sub-function level throughout the model, and following this we are able
to determine the sources of structural error that have an important impact on
the output uncertainty. Without the model decomposition and variance based
sensitivity analysis it may not be at all obvious which are the most important
sources of structural error, and so the method reveals features of the model that
are otherwise hidden.
As is clear from our description of the model in section 2.1, a model's struc-
ture rests upon a series of assumptions regarding the relationships between the
inputs, the intermediate parameters and the output. In any modelling process it
is unavoidable that such assumptions are made, and in one sense model building
is just a formal representation of a set of assumptions in mathematical functional
form. Health economic modellers sometimes explore the sensitivity of the model
prediction to underlying assumptions in a \what if" scenario analysis in which sets
of alternative assumptions are modelled (see Bojke et al. (2009) for a review of
the methods that are currently used to manage health economic evaluation model
uncertainty, and Kim et al. (2010) for a specic example of modelling alternative
scenarios). However, this process cannot in any formal sense quantify the sen-
sitivity of the results to the assumptions, and nor can it quantify any resulting
prediction uncertainty. Our method is an attempt to formally quantify the eect
of all assumptions in the model about which we do not have complete certainty.
The method is most useful as a sensitivity analysis tool, highlighting areas
of the model that may require further thought. However, if the modeller can
satisfactorily specify a joint distribution for the inputs and the discrepancies,
then the method results in a proper quantication of uncertainty about the `true'
incremental net benet of one decision over an alternative, taking into account
judgements about both parameters and structure.
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6.1 Model complexity and parsimony
Current good practice guidance on modelling for health economic evaluation states
that a model should only be as complex as necessary (Weinstein et al., 2003), but
this well intentioned advice does not actually help us make judgements about
how complex any particular model should be. Another guiding principle is the
requirement for a model to be comprehensible to the non-modeller: a decision
maker's trust in a model can easily be eroded if the model is so complicated that
its features cannot be easily communicated (Taylor-Robinson et al., 2008).
Our view is that, in the health economic context, increasing the model com-
plexity has the eect of transferring uncertainty about structural error, which we
express through the specication of model discrepancy terms, to uncertainty about
model input parameters. Structural error arises when a simple model is used to
a model a complex real world process, thereby omitting aspects that could eect
costs or consequences. If we make the model more complex by including such
omitted features, typically we will then have more input parameters in the model.
Increasing the complexity of a model will therefore be desirable if the addi-
tional complexity relates to parts of the model in which discrepancy terms are
inuential, and if we have suitable data to tell us about any extra parameters
that are required. This is because, to the decision-maker, data-driven probability
distributions for model parameters will be preferable to distributions on (plausibly
large) discrepancy terms based solely on subjective judgements of the modeller.
Our framework can help guide the choice of model complexity by identifying
which discrepancy terms are likely to be important. If we are satised that a
structural error will have little eect on the model output, then increasing the
complexity of the model to reduce such an error is likely to have little benet.
6.2 Extension to a scenario with more than two decision
options
In our case study there were two competing decisions, and therefore a single ob-
vious scalar model output quantity: the incremental net benet. This allowed
a straightforward analysis of sub-function discrepancy importance using the vari-
ance based sensitivity method. However, when there are more than two competing
decisions there is no single, scalar model output that is equivalent of the incremen-
tal net benet, and therefore it is not immediately obvious how to proceed with
variance based sensitivity methods. One solution would be to work instead within
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an expected value of information framework, dening important model sub-unit
discrepancy terms as those which have an expected value above some threshold.
6.3 How might this work in practice?
We envisage that the sub-function discrepancy approach has the greatest poten-
tial if used prospectively during model building. This will allow the modeller to
incorporate judgements about structural error as they construct the model, en-
couraging an explicit recognition of the potential impact of the structural choices.
Model development is a sequential, hierarchical, iterative process of uncovering
and evaluating options regarding structure, parameterisation and incorporation of
evidence (Chilcott et al., 2010a). The process depends on the modeller developing
an understanding of the decision problem, which is by its nature subjective. This
understanding of the decision problem is the foundation upon which judgements
are made in the model building process, and also provides the basis for making
judgements about the likely discrepancy inherent in dierent model formulations.
The essence of the discrepancy approach is that it allows a formal quantication
of the impact of the choices made throughout the model building process.
Ultimately, the validity of the method relies on the ability to meaningfully
specify the joint distribution of inputs and discrepancies, p(X; ). In our study
we represented our beliefs about p(X; ) fairly crudely, making assumptions of
independence between inputs and discrepancies and independence between groups
of discrepancies that were not otherwise constrained. Key to the specication of
the discrepancy in our case study was the choice of values for vi that control the
variance of i relative to the mean of the corresponding intermediate parameter.
We determined a value for each vi by informally eliciting our own judgements
about the plausible range for the structural error relative to the size of the in-
termediate parameter. We then examined the eect of making dierent sets of
choices in a sensitivity analysis.
Whilst we felt that this was sucient in our case study for the purposes of
identifying important model sub-functions we recognise that making defensible
judgements about model discrepancies is in general likely to be dicult. If we wish
to proceed to a full quantication of our uncertainty about the target quantity
via Z = f (X; ) then a more sophisticated specication of p(X; ) will typically
be required. Developing practical methods for making helpful judgements about
p(X; ) is an area for future research.
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Appendix A - Base case model input parameters
Table 2: Uncertain inputs and their distributions
Input Label Description Distribution Hyperparameters
X1 c0 Intervention cost ($) gamma shape=100; scale=1
X2 tchd Total NHS costs (2005) for CHD ($) gamma sh=3:677109; sc=1
X3 tstr Total NHS costs (2005) for stroke ($) gamma sh=2:872109; sc=1
X4 tdm Total NHS costs (2005) for diabetes ($) gamma sh=5:314109; sc=1
X5 nchd Number of UK cases of CHD Poisson  = 2:60 106
X6 nstr Number of UK cases of stroke Poisson  = 1:40 106
X7 ndm Number of UK cases of diabetes Poisson  = 1:53 106
X8 q
(dec)
chd Discounted decremental health eect for CHD
(QALYs)
normal  = 6:71;  = 0:048
X9 q
(dec)
str Discounted decremental health eect for stroke
(QALYs)
normal  = 10:23;  = 0:048
X10 q
(dec)
dm Discounted decremental health eect for DM
(QALYs)
normal  = 2:08;  = 0:048
X11 p
(ex)
1 Probability of new exercise - non-intervention group MVN
 = 0:246;  = 0:038
 = 0:5
X12 p
(ex)
2 Probability of new exercise - intervention group  = 0:294;  = 0:040
X13 p
(mnt)
1 Probability exercise is maintained - non-intervention MVN
 = 0:5;  = 0:1
 = 0:9
X14 p
(mnt)
2 Probability exercise is maintained - intervention  = 0:5;  = 0:1
X15 r
(sed)
chd Risk of CHD in a sedentary group beta  = 80;  = 385
X16 r
(sed)
str Risk of stroke in a sedentary group beta  = 226;  = 4072
X17 r
(sed)
dm Risk of diabetes in a sedentary group beta  = 346;  = 3344
X18 RRchd Relative risk of CHD in active vs sedentary pop lognormal  = 0:666;  = 0:130
X19 RRstr Relative risk of stroke in active vs sedentary pop lognormal  = 0:720;  = 0:343
X20 RRdm Relative risk of diabetes in active vs sedentary pop lognormal  = 0:710;  = 0:123
X21 age(onst) Average age of onset of disease (same for all diseases) normal  = 57:5;  = 2
X22 age
(dth)
chd Average age of death for CHD (years) normal  = 71;  = 2
X23 age
(dth)
str Average age of death for stroke (years) normal  = 59;  = 2
X24 age
(dth)
dm Average age of death for diabetes (years) normal  = 61;  = 2
Table 3: Fixed inputs
Input Label Description Value
X25 age(int) Average age of cohort at time of intervention (years) 50
X26  Discount rate (per year) 0.035
X27  Willingness to pay ($/QALY) 20,000
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Appendix B - Algorithm for calculating main ef-
fect index when model inputs are correlated
We have a model y = f(x) with p inputs, x = fx1; : : : ; xpg and a scalar output
y. We are uncertain about the input values, and therefore write X and represent
beliefs via p(X). Note that to use this method to determine the main eect
indexes for the discrepancy terms, , we treat the discrepancies as just another
set of uncertain model inputs, so in the description below,  would be included in
the vector of all uncertain input quantities, X.
We are interested in the sensitivity of the model output to the p model inputs
and measure this using the `main eect index', dened for input Xi as
varXifEX i(Y jXi)g
var(Y )
; (28)
where X i = fX1; : : : ; Xi 1; Xi+1 : : : ; Xpg.
At rst sight this is non-trivial via Monte Carlo methods if Xi is not indepen-
dent of X i since calculating EX i(Y jXi) requires sampling from the conditional
distribution X ijXi, which may not be explicitly known. We therefore suggest
the following alternative method, which does not require us to sample from the
conditional distributions.
We rst obtain a single Monte Carlo sampleM = f(xs; ys); s = 1; : : : ; Sg where
xs are drawn from the joint distribution of the inputs, p(X), and ys = f(xs) are
evaluations of the model output. We represent M as the matrix
M =
0BBBB@
x1;1 x2;1 : : : xi;1 : : : xp;1 y1
x1;2 x2;2 : : : xi;2 : : : xp;2 y2
...
...
...
...
...
...
...
x1;S x2;S : : : xi;S : : : xp;S yS
1CCCCA : (29)
We then extract the xi and y columns and then reorder this matrix row-wise with
respect to xi, giving
Mi =
0BBBB@
xi;(1) y(1)
xi;(2) y(2)
...
...
xi;(S) y(S)
1CCCCA ; (30)
where xi;(1)  xi;(2)  : : :  xi;(S), and y(s) is the model evaluated at x(s).
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Next, we divide the output y(1); : : : ; y(S) into K vectors, each of length b so
that S = Kb, i.e. fy(1); : : : ; y(b)g; fy(b+1); : : : ; y(2b)g; : : : ; fy(S b+1); : : : ; y(S)g. The
`bandwidth' b is chosen to be small compared with the size of S.
We can obtain the main eect index either directly from the variance of the
conditional expectation, or from the expectation of the conditional variance via
the identity varXifEX i(Y jXi)g = var(Y )   EXifvarX i(Y jXi)g. Numerical sta-
bility of the algorithm with respect to the choice of d is improved if the expectation
of the conditional variance, rather than the variance of the conditional expecta-
tion is approximated, and we therefore calculate EXifvarX i(Y jXi)g, which we
approximate as
EXifvarX i(Y jXi)g 
1
K
KX
k=1
8<:1b
bkX
j=b(k 1)+1
 
y(j)   yk
29=; ; (31)
where yk =
1
b
Pdk
j=b(k 1)+1 y(j).
By re-ordering each Mi with respect to xi, the main eect indexes for all p
inputs can be obtained from a single Monte Carlo sample M .
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Appendix C - Distribution for sum-to-one param-
eters
We denote a sum-to-one intermediate parameter as Y = (Y1; : : : ; Yn), where Yj 2
[0; 1] 8j and Pnj=1 Yj = 1.
The true unknown value of the intermediate parameter is denotedZ = (Z1; : : : ; Zn)
where Z = Y + Y and Y = (Y1 ; : : : ; Yn). The same constraints apply to Z as
to Y , i.e. Zj 2 [0; 1] 8j and
Pn
j=1 Zj = 1.
We state the following beliefs about Y . Firstly, that E(Yj) = 0 8j, and
secondly that the mean of the ratio of the standard deviation of the discrepancy
to the expected value of the parameter is some constant v, i.e. that
1
n
nX
j=1
p
var(Yj)
E(Yj)
= v: (32)
We generate a sample from p(Z) as follows. Firstly, we sample fys; s =
1; : : : ; Sg from p(Y ). Conditional on Y we then generate a sample fzs; s =
1; : : : ; Sg from p(Z), where each zs is a single draw from p(ZjY = ys). The
conditional distribution of ZjY = ys is Dirichlet with hyperparameter vector
ys = (y1;s; : : : ; yn;s).
The expectation of Yj is
E(Yj) = E(Zj)  E(Yj) = EYifEZj(ZjjYj)g   E(Yj) = 0; (33)
as required. The variance of Yj is
var(Yj) = var(Zj) + var(Yj)  2Cov(Zj; Yj) (34)
= EYjfvarZj(ZjjYj)g+ varYjfEZj(ZjjYj)g+ var(Yj)  2cov(Zj; Yj)(35)
= EYjfvarZj(ZjjYj)g+ varYjfEZj(ZjjYj)g+ var(Yj)  2var(Yj) (36)
= EYjfvarZj(ZjjYj)g+ var(Yj) + var(Yj)  2var(Yj) (37)
= EYjfvarZj(ZjjYj)g (38)
= EYj

(Yj(1  Yj)
 + 1

(39)
=
E(Yj)f1  E(Yj)g
 + 1
  var(Yj)
 + 1
(40)
 E(Yj)f1  E(Yj)g
 + 1
: (41)
The nal step follows because
var(Yj)
+1
is small relative to
E(Yj)f1 E(Yj)g
+1
.
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The hyperparameter  is chosen such that the mean of the ratio of the standard
deviation to the expected value of the parameter is v, i.e. so that
1
n
nX
j=1
p
var(Yj)
E(Yj)
=
1
n
nX
j=1
q
E(Yj)f1 E(Yj)g
+1
E(Yj)
= v: (42)
Approximating E(Yj) by the sample mean yj and rearranging gives
 =
1
v2
(
1
n
nX
j=1
s
1  yj
yj
)2
  1: (43)
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